SPT-320, a lymphatic-targeting prodrug of agomelatine that avoids first-pass hepatic metabolism

Neuroscience Applied 2026 Open access

Read full text

Authors: J. Simpson, T. Quach, E. Pierce, D. Bonner, M. Chen

DOI: 10.1016/j.nsa.2025.106064

Cited by: 0

Fields of Study & Subjects

Mast cells and histamine Circadian rhythm and melatonin Lymphatic System and Diseases